{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 23,
        "end": 32
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 37,
        "end": 47
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 51,
        "end": 57
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 77,
        "end": 81
      }
    },
    {
      "id": "T5",
      "obj": "Disease",
      "span": {
        "begin": 110,
        "end": 122
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 23,
        "end": 47
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "25902899_1",
  "text": "Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/ PTEN loss patients with advanced solid tumors refractory to standard therapy ."
}
